Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study

Background: Ivermectin is a drug that has been shown to be active against coronavirus disease 19 (COVID-19) in previous studies. Healthcare personnel are highly exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Therefore, we decided to offer them ivermectin as a pre-...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgenstern, Jose, Redondo, Jose N, Olavarria, Alvaro, Rondon, Isis, Roca, Santiago, De Leon, Albida, Canela, Juan, Tavares, Johnny, Minaya, Miguelina, Lopez, Oscar, Castillo, Ana, Placido, Ana, Cruz, Rafael, Merette, Yudelka, Toribio, Marlenin, Francisco, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Preventive Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405705/
https://www.ncbi.nlm.nih.gov/pubmed/34513523
http://dx.doi.org/10.7759/cureus.17455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405705/
https://www.ncbi.nlm.nih.gov/pubmed/34513523
http://dx.doi.org/10.7759/cureus.17455

Ejemplares similares